课题基金 / 基金详情

Myc Physiology in the Pancreatic Beta Cell

Myc Physiology in the Pancreatic Beta Cell
胰腺 Beta 细胞中的 Myc 生理学
批准号:
10399579
负责人:
Adolfo Garcia-Ocana
金额:
$50.25万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-28 至 2024-04-30

项目摘要

项目成果

Adolfo Garcia-Ocana的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病患者将受益于增加功能性β细胞质量的疗法。β-细胞通过扩大其功能质量来自然适应增加的代谢需求和胰岛素抵抗,这一过程随着衰老而减少。我们最近已经证明了Myc在年轻而非老年小鼠中功能性β细胞的适应性扩增中的关键作用。尽管有多项研究描述了Myc在β细胞中过表达的影响,但关于这种关键的合成代谢转录因子如何感知和响应营养物质以及在其天然环境中增加胰岛素需求的知识存在差距。营养素如何调节β细胞中Myc的表达?Myc如何参与β细胞中GSIS和线粒体功能的调节,Myc如何不能增加衰老β细胞中的适应性增殖,或者特定Myc结合位点的靶向去甲基化是否会增加代谢应激的衰老β细胞中的β细胞增殖?这些关于Myc在β细胞中的生理作用的重要问题需要得到回答,以推进我们的知识并找到治疗糖尿病的治疗方法。我们的总体假设是Myc对于适应性β细胞生长和功能至关重要,并且逆转T2 D易感或代谢应激的老年β细胞中的Myc抗性可导致增强的适应性反应。我们将通过完成以下具体目标来验证我们的假设:1)阐明营养素如何生理性上调β细胞中Myc,以及Myc上调是否是胰岛素抵抗中适应性葡萄糖和β细胞稳态所必需的; 2)确定Myc对β细胞中胰岛素分泌和线粒体生物能量学的生理作用;(3)揭示和改变代谢应激、衰老和T2 D β细胞中Myc作用受损的机制。这些研究将提供前所未有的洞察Myc如何受营养素调节,Myc如何调节β细胞功能以及如何克服代谢应激的老年β细胞中的Myc抗性,这将为设计和测试治疗糖尿病的新治疗策略提供关键的基础平台。
英文摘要
Patients with diabetes would benefit from therapies that increase functional β-cell mass. β-cells naturally adapt to increased metabolic demand and insulin resistance by expanding their functional mass, a process that decreases with aging. We have recently demonstrated a critical role for Myc in adaptive expansion of functional β-cells in young but not old mice. Despite multiple studies describing the effect of Myc overexpression in beta cells, there is a knowledge gap about how this crucial anabolic transcription factor perceives and responds to nutrients and increased insulin demand in its native context. How do nutrients regulate Myc expression in β-cells? How does Myc participate in the regulation of GSIS and mitochondrial function in the β-cell, how does Myc fail to increase adaptive proliferation in aged β-cells or will targeted demethylation of specific Myc binding sites increase β-cell proliferation in metabolically-stressed aged β-cells? These important questions about the physiological role of Myc in the β-cell need to be answered to advance our knowledge and find therapeutic means to treat diabetes. Our overarching hypothesis is that Myc is critical for adaptive β-cell growth and function, and reversing Myc resistance in the T2D-prone or metabolically-stressed aged β-cell can lead to an enhanced adaptive response. We will test our hypothesis by completing the following specific aims: 1) To elucidate how nutrients physiologically upregulate Myc in β-cells and whether Myc upregulation is required for adaptive glucose and β-cell homeostasis in insulin resistance; 2) To determine the physiological role of Myc on insulin secretion and mitochondrial bioenergetics in the β-cell; and, 3) To uncover and modify the mechanisms impairing Myc action in the metabolically-stressed, aged, and T2D β-cells. These studies will deliver unprecedented insight into how Myc is regulated by nutrients, how Myc regulates β-cell function and how to overcome Myc resistance in the metabolically-stressed aged β-cell, which will provide a crucial basic platform for designing and testing novel therapeutic strategies for the treatment of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myc Physiology in the Pancreatic Beta Cell
Myc Physiology in the Pancreatic Beta Cell
Dextran Sulfate, Beta Cell Preservation and Immune Regulation in Type 1 Diabetes
Protein Kinase C (PKC) Zeta and the Pancreatic Beta Cell
海外基金